Mirage News
– Launched 14 critical injectable medicines since Company inception in October 2023 and remains on track to meet target of 25+ products by year-end 2025 – Pursuing two-pronged portfolio development strategy to establish strong foundation of critical injectable products while ensuring long-term competitiveness and return on investment – Company to attend the 43rd Annual J.P.
Read More
Avenacy Updates 2025 Strategy Before J.P. Morgan Event | Mirage News
Mirage News
18:21
– Launched 14 critical injectable medicines since Company inception in October 2023 and remains on track to meet target of 25+ products by year-end 2025 – Pursuing two-pronged portfolio development strategy to establish strong foundation of critical injectable products while ensuring long-term competitiveness and return on investment – Company to attend the 43rd Annual J.P.
